Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.
暂无分享,去创建一个
Michelle P. Salyers | G L Wolford | G. Wolford | M. Swartz | S. Rosenberg | M. Salyers | S. Essock | F. Osher | L. Goodman | L A Goodman | S D Rosenberg | N. Constantine | F C Osher | M S Swartz | N T Constantine | S M Essock | M I Butterfield | M P Salyers | M. Butterfield | M. Salyers | M. Swartz
[1] H. Goldman,et al. Defining and counting the chronically mentally ill. , 1981, Hospital & community psychiatry.
[2] E. Susser,et al. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness. , 1998, Archives of General Psychiatry.
[3] L. Y. Stevenson,et al. Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention. , 1997, Psychiatric services.
[4] H. Margolis,et al. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .
[5] F. Cournos,et al. HIV seroprevalence among people with severe mental illness in the United States: a critical review. , 1997, Clinical psychology review.
[6] F. Cournos,et al. AIDS and people with severe mental illness : a handbook for mental health professionals , 1996 .
[7] Ting Chang,et al. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan , 1993, Journal of medical virology.
[8] Ronald W. Manderscheid,et al. Mental Health in the United States , 1962, Nature.
[9] F. Cournos,et al. HIV infection linked to substance use among hospitalized patients with severe mental illness. , 1998, Psychiatric services.
[10] H. El‐Serag,et al. Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.
[11] Alter Mj,et al. The epidemiology of viral hepatitis in the United States. , 1994 .
[12] J. Kelly,et al. HIV risk reduction interventions for persons with severe mental illness. , 1997, Clinical psychology review.
[13] D. Vlahov,et al. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[14] O. Weiland,et al. Combined treatment with interferon alpha‐2b and ribavirin for chronic hepatitis C in patients with a previous non‐response or non‐sustained response to interferon alone , 1995, Journal of medical virology.
[15] R. Drake,et al. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. , 1998, The American journal of psychiatry.
[16] K. Carey,et al. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. , 1997, Clinical psychology review.
[17] Eugene R. Schiff,et al. Schiff's Diseases of the Liver , 1999 .
[18] R. Drake,et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders. , 1998, Schizophrenia bulletin.
[19] S. Kalichman,et al. Factors associated with risk for HIV infection among chronic mentally ill adults. , 1994, The American journal of psychiatry.
[20] J. Hoofnagle,et al. Serologic markers of hepatitis B virus infection. , 1986, Seminars in liver disease.
[21] J. Talbott. The Chronic mental patient : five years later , 1984 .
[22] G. Barbarini,et al. Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. , 1999, The American journal of medicine.
[23] K. Carey,et al. PREVALENCE OF INFECTION WITH HIV AMONG THE SERIOUSLY MENTALLY ILL: REVIEW OF RESEARCH AND IMPLICATIONS FOR PRACTICE , 1995 .
[24] A. Schinnar,et al. An empirical literature review of definitions of severe and persistent mental illness. , 1990, The American journal of psychiatry.